These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38881078)

  • 21. Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience.
    Chapple CR
    Eur Urol; 1996; 29(2):129-44. PubMed ID: 8647139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist.
    Beduschi MC; Beduschi R; Oesterling JE
    Urology; 1998 Jun; 51(6):861-72. PubMed ID: 9609620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects by silodosin on the partially obstructed rat ureter in vivo and on human and rat isolated ureters.
    Villa L; Buono R; Fossati N; Rigatti P; Montorsi F; Benigni F; Hedlund P
    Br J Pharmacol; 2013 May; 169(1):230-8. PubMed ID: 23373675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
    Buzelin JM; Fonteyne E; Kontturi M; Witjes WP; Khan A
    Br J Urol; 1997 Oct; 80(4):597-605. PubMed ID: 9352699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive monotherapy and cardiovascular responses to an acoustic startle stimulus.
    Girard A; Holand S; Laude D; Elghozi JL
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):101-7. PubMed ID: 11152367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of terazosin therapy on blood pressure in men with benign prostatic hyperplasia concurrently treated with other antihypertensive medications.
    Lowe FC; Olson PJ; Padley RJ
    Urology; 1999 Jul; 54(1):81-5. PubMed ID: 10414731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.
    Pande S; Hazra A; Kundu AK
    Indian J Pharmacol; 2014; 46(6):601-7. PubMed ID: 25538330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
    Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
    Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of α
    Yoshizumi M; Ise SN; Yonezawa A; Watanabe C; Sakurada S; Mizoguchi H
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):704-711. PubMed ID: 38409579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the design and synthesis of prazosin derivatives over the last ten years.
    Desiniotis A; Kyprianou N
    Expert Opin Ther Targets; 2011 Dec; 15(12):1405-18. PubMed ID: 22148952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular reactivity to isometric stress in patients with stable and borderline hypertension and in normotensive subjects. Effects of alpha sympatholytics and beta blocking agents].
    Colombo F; Porro T; Orlandi L; Borchini M; Libretti A
    Cardiologia; 1990 Mar; 35(3):211-6. PubMed ID: 2245422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
    Yu HJ; Lin AT; Yang SS; Tsui KH; Wu HC; Cheng CL; Cheng HL; Wu TT; Chiang PH
    BJU Int; 2011 Dec; 108(11):1843-8. PubMed ID: 21592295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.
    Paick JS; Cho MC; Song SH; Kim SW; Ku JH
    J Korean Med Sci; 2008 Jun; 23(3):509-13. PubMed ID: 18583890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
    Sato S; Hatanaka T; Yuyama H; Ukai M; Noguchi Y; Ohtake A; Taguchi K; Sasamata M; Miyata K
    Biol Pharm Bull; 2012; 35(1):72-7. PubMed ID: 22223340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.
    Schäfers RF; Fokuhl B; Wasmuth A; Schumacher H; Taguchi K; de Mey C; Philipp T; Michel MC
    Br J Clin Pharmacol; 1999 Jan; 47(1):67-74. PubMed ID: 10073742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse.
    Sohn JH; Lee SH; Kwon YS; Kim JH; Kim Y; Lee JJ
    Medicine (Baltimore); 2020 May; 99(22):e20240. PubMed ID: 32481389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
    Singh I; Tk A; Gupta S
    Int J Clin Pract; 2020 Aug; 74(8):e13530. PubMed ID: 32542854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.